000 01285 a2200385 4500
005 20250511162017.0
264 0 _c19770125
008 197701s 0 0 eng d
022 _a0028-4793
024 7 _a10.1056/NEJM197612232952608
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRosen, F S
245 0 0 _aAndrogen therapy in hereditary angioneurotic edema.
_h[electronic resource]
260 _bThe New England journal of medicine
_cDec 1976
300 _a1476-7 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAndrogens
_xtherapeutic use
650 0 4 _aAngioedema
_xdrug therapy
650 0 4 _aCapillary Permeability
650 0 4 _aChild
650 0 4 _aComplement C1 Inactivator Proteins
650 0 4 _aDanazol
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aGlycoproteins
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aKallikreins
_xantagonists & inhibitors
650 0 4 _aMethyltestosterone
_xtherapeutic use
650 0 4 _aPregnancy
650 0 4 _aRNA, Messenger
_xbiosynthesis
650 0 4 _aSuppression, Genetic
700 1 _aAusten, K F
773 0 _tThe New England journal of medicine
_gvol. 295
_gno. 26
_gp. 1476-7
856 4 0 _uhttps://doi.org/10.1056/NEJM197612232952608
_zAvailable from publisher's website
999 _c1002635
_d1002635